CASI Pharmaceuticals, Inc (DE) Quarterly Earnings Per Share, Basic in USD/shares from Q1 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2021 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Earnings Per Share, Basic for the quarter ending December 31, 2022 was -2.01 USD/shares, a 48.9% decline year-over-year.
  • CASI Pharmaceuticals, Inc (DE) Earnings Per Share, Basic for the twelve months ending December 31, 2022 was -3.01 USD/shares, a 11.9% decline year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Earnings Per Share, Basic for 2022 was -3.01 USD/shares, a 11.9% decline from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Earnings Per Share, Basic for 2021 was -2.69 USD/shares, a 38.4% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$3 -$2 -$1 -48.9% Oct 1, 2022 Dec 31, 2022 20-F 2023-04-26
Q3 2022 -$2 $0 +$0.35 +47.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$3 -$1 $0 -12% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 -$3 $0 +$0.05 +45.5% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$3 -$1 Oct 1, 2021 Dec 31, 2021 20-F 2023-04-26
Q3 2021 -$1 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.